These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35199295)

  • 1. Clinicopathological Review of Micropapillary Urothelial Carcinoma.
    Kumar D; Adeniran AJ
    Curr Oncol Rep; 2022 May; 24(5):603-610. PubMed ID: 35199295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
    Schneider SA; Sukov WR; Frank I; Boorjian SA; Costello BA; Tarrell RF; Thapa P; Houston Thompson R; Tollefson MK; Jeffrey Karnes R; Cheville JC
    Mod Pathol; 2014 May; 27(5):758-64. PubMed ID: 24186136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
    Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
    Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Isharwal S; Huang H; Nanjangud G; Audenet F; Chen YB; Gopalan A; Fine SW; Tickoo SK; Lee BH; Iyer G; Chadalavada K; Rosenberg JE; Bajorin DF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Solit DB; Reuter VE; Al-Ahmadie HA
    Hum Pathol; 2018 Jul; 77():63-69. PubMed ID: 29601842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
    Amin A; Epstein JI
    Hum Pathol; 2012 Dec; 43(12):2124-8. PubMed ID: 22939957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
    HacihasanoĞlu E; YÜcetaŞ U; OkÇu O; BehzatoĞlu K
    Turk Patoloji Derg; 2021; 37(1):26-31. PubMed ID: 32692402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.
    Sangoi AR; Cox RM; Higgins JP; Quick CM; McKenney JK
    Histopathology; 2020 Nov; 77(5):728-733. PubMed ID: 32443178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis.
    Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q
    Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
    Posada JM; Yakirevich E; Kamat AM; Sood A; Jacob JM; Bratslavsky G; Grivas P; Spiess PE; Li R; Necchi A; Mega AE; Golijanin DJ; Pavlick D; Huang RSP; Lin D; Danziger N; Sokol ES; Sivakumar S; Ross JS; Cheng L
    Mod Pathol; 2024 Mar; 37(3):100424. PubMed ID: 38219954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.
    Wang BG; Woodward K; Menezes G; Wang ZQ; He R; Li W
    Diagn Cytopathol; 2022 Sep; 50(9):E248-E254. PubMed ID: 35560555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.
    Sangoi AR; Beck AH; Amin MB; Cheng L; Epstein JI; Hansel DE; Iczkowski KA; Lopez-Beltran A; Oliva E; Paner GP; Reuter VE; Ro JY; Shah RB; Shen SS; Tamboli P; McKenney JK
    Am J Surg Pathol; 2010 Sep; 34(9):1367-76. PubMed ID: 20717002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.
    Al-Ahmadie H; Iyer G
    Surg Pathol Clin; 2018 Dec; 11(4):713-723. PubMed ID: 30447837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
    Shah TS; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff DJ; Chen G; Warrick JI
    Hum Pathol; 2017 Mar; 61():90-96. PubMed ID: 27818288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropapillary urothelial carcinoma of the ureter.
    Radulović P; Kraus O; Krušlin B
    Cesk Patol; 2012 Apr; 48(2):100-2. PubMed ID: 22716062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
    Tajima S; Koda K
    Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.